Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.020
+0.210 (25.91%)
At close: Jun 6, 2025, 4:00 PM
1.040
+0.020 (1.96%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $164.98 million as of June 6, 2025. Its market cap has decreased by -89.33% in one year.
Market Cap
164.98M
Enterprise Value
-83.43M
1-Year Change
-89.33%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $164.98M, a decrease of -93.61%. That is a compound annual growth rate of -79.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 131.03M | -92.35% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |